Ingmar Blümcke Selected Research

Focal Cortical Dysplasia

3/2022	MRI of focal cortical dysplasia.
2/2019	A comprehensive clinico-pathological and genetic evaluation of bottom-of-sulcus focal cortical dysplasia in patients with difficult-to-localize focal epilepsy.
1/2019	Genomic DNA methylation distinguishes subtypes of human focal cortical dysplasia.
2/2016	LRP12 silencing during brain development results in cortical dyslamination and seizure sensitization.
2/2012	Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI.
9/2010	Focal Cortical Dysplasias: clinical implication of neuropathological classification systems.
9/2009	Malformations of cortical development and epilepsies: neuropathological findings with emphasis on focal cortical dysplasia.
12/2006	Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias.
10/2004	CD34-immunoreactive balloon cells in cortical malformations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ingmar Blümcke Research Topics

Disease

23	Neoplasms (Cancer) 01/2022 - 04/2005
22	Epilepsy (Aura) 01/2022 - 08/2003
14	Partial Epilepsies (Epilepsy, Partial) 01/2022 - 07/2005
9	Tuberous Sclerosis (Bourneville's Disease) 11/2022 - 08/2004
9	Focal Cortical Dysplasia 03/2022 - 10/2004
9	Seizures (Absence Seizure) 01/2022 - 11/2003
8	Glioma (Gliomas) 01/2022 - 04/2005
7	Craniopharyngioma (Craniopharyngiomas) 07/2011 - 03/2006
5	Astrocytoma (Pilocytic Astrocytoma) 11/2022 - 11/2017
4	Brain Neoplasms (Brain Tumor) 11/2022 - 05/2006
4	Temporal Lobe Epilepsy 01/2022 - 05/2012
4	Drug Resistant Epilepsy 01/2022 - 05/2009
4	Ganglioglioma 06/2018 - 07/2002
4	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 10/2009 - 07/2006
3	Hyperplasia 03/2022 - 10/2019
3	Malformations of Cortical Development 03/2022 - 10/2019
3	Glioblastoma (Glioblastoma Multiforme) 06/2018 - 05/2006
3	Encephalitis (Encephalitis, Rasmussen) 09/2015 - 05/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2014 - 02/2008
3	Hippocampal Sclerosis 07/2013 - 05/2008
2	Intervertebral Disc Displacement (Herniated Disc) 06/2022 - 01/2021
2	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 01/2022 - 03/2010
2	Lymphoma (Lymphomas) 01/2021 - 06/2005
2	Neurocutaneous Syndromes (Phakomatoses) 01/2020 - 07/2005
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2018 - 11/2003
2	Huntington Disease (Huntington's Disease) 10/2010 - 02/2008
2	Stroke (Strokes) 10/2009 - 02/2008
1	Neuralgia (Stump Neuralgia) 06/2022
1	Pain (Aches) 06/2022
1	Oligodendroglioma 01/2022
1	Hydrocephalus (Hydrocephaly) 01/2020
1	Frontal Lobe Epilepsy (Epilepsy, Supplementary Motor) 10/2019
1	Carcinogenesis 06/2018
1	Sclerosis 01/2017
1	Focal cortical dysplasia of Taylor 01/2016
1	Dementia (Dementias) 10/2015
1	Cognitive Dysfunction 10/2015
1	Neuroinflammatory Diseases 10/2015
1	Cardiomyopathies (Cardiomyopathy) 08/2015
1	Viral Encephalitis 09/2013
1	Genomic Instability 12/2012

Drug/Important Bio-Agent (IBA)

23	Pharmaceutical PreparationsIBA 01/2022 - 07/2005
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2005
8	trans-sodium crocetinate (crocetin)IBA 11/2022 - 08/2004
6	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020 - 05/2008
6	Histone Deacetylases (Histone Deacetylase)IBA 01/2009 - 05/2005
4	beta CateninIBA 05/2010 - 12/2006
4	Histone Deacetylase InhibitorsIBA 10/2009 - 05/2006
3	mitomycin C-dextranIBA 03/2022 - 09/2009
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2014
3	AntibodiesIBA 01/2018 - 03/2010
3	Histones (Histone)IBA 05/2013 - 05/2006
3	ChromatinIBA 07/2011 - 05/2005
3	Vorinostat FDA Link 08/2006 - 05/2005
2	Sirolimus (Rapamycin)FDA Link 11/2022 - 01/2022
2	AntigensIBA 01/2021 - 05/2012
2	TOR Serine-Threonine KinasesIBA 01/2016 - 01/2016
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 05/2012 - 03/2007
2	fascinIBA 07/2011 - 05/2010
2	Troglitazone (Rezulin)FDA Link 01/2008 - 06/2007
2	PPAR gammaIBA 01/2008 - 06/2007
2	Transforming Growth Factor beta (TGF-beta)IBA 06/2007 - 09/2005
2	Insulin (Novolin)FDA Link 12/2006 - 07/2002
2	entinostat (MS 275)IBA 08/2006 - 05/2006
2	benzamideIBA 08/2006 - 05/2006
2	enhanced green fluorescent proteinIBA 05/2006 - 04/2005
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	GlucocorticoidsIBA 01/2022
1	2,6-dinitrotoluene (DNT)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	Vitamin B 6IBA 02/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 06/2018
1	Losartan (Cozaar)FDA LinkGeneric 01/2018
1	Isoflurane FDA LinkGeneric 01/2018
1	AlbuminsIBA 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	HMGB1 Protein (HMG1)IBA 01/2018
1	Coenzyme A (CoA)IBA 01/2017
1	Lipoproteins (Lipoprotein)IBA 02/2016
1	Pentylenetetrazole (Metrazol)IBA 02/2016
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 10/2015
1	montelukast (Singulair)FDA Link 10/2015
1	Leukotriene Receptors (Leukotriene Receptor)IBA 10/2015
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2015
1	Keratins (Keratin)IBA 01/2014
1	InterferonsIBA 09/2013
1	Untranslated RNA (Noncoding RNA)IBA 05/2013
1	DNA Transposable Elements (Element, IS)IBA 12/2012

Therapy/Procedure

16	Therapeutics 06/2022 - 09/2005
2	Conservative Treatment 06/2022 - 01/2021
1	Aftercare (After-Treatment) 06/2022
1	Precision Medicine 02/2021
1	Topical Administration 01/2018
1	Rejuvenation 10/2015
1	Hemispherectomy 03/2013